Crossmark

Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin–angiotensin–aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study

Crossref DOI link: https://doi.org/10.1007/s11033-022-07183-w

Published Online: 2022-01-31

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moustafa, Diala Alhaj

Imran, Zainab

Ismail, Roua

Rayan, Menatallah

Gadeau, Alain-Pierre

Eldassouki, Hussein

Abdulrahman, Nabeel

Mraiche, Fatima https://orcid.org/0000-0001-6188-1145
Funding

Funding for this research was provided by:

Qatar University (QUST-2-CPH-2020-16)
License Information

Text and Data Mining valid from 2022-01-31

Version of Record valid from 2022-01-31
More Information

Article History

Received: 17 September 2021

Accepted: 20 January 2022

First Online: 31 January 2022

Declarations

:

: The authors have no conflicts of interest to declare that are relevant to the content of this article.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Not applicable.

: Not applicable.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below